Pregabalin Capsules, Cv Capsule
Product Images NDC 69097-685

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Pregabalin Capsules, Cv (NDC 69097-685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 01

This appears to be a formula to estimate creatinine clearance based on age, weight, and serum creatinine level, with a correction factor for female patients. However, there appears to be a typo in the formula - "ferale" should be "female".*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 02

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 03

This is a chart showing the percentage of patients who improved, with respect to pain, after treatment. The X-axis displays the range of values from 0 to 290, while the Y-axis displays the percentage of patients improved.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 04

This text is not clear. It seems to contain some errors which makes it difficult to understand the context. Therefore, the description cannot be generated.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 05

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 06

This appears to be a graph or chart showing the percentage of patients who experienced improvement in pain after taking a medication called "Pragabaln" at a dosage of 100mg per day. The chart also includes a line graph showing the percentage improvement in pain from baseline.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 07

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 08

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 09

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 10

This is a report showing the "Responder Rate" percentage, with a value of 60%. Additional data is present but is unclear due to errors affecting the numbers and units.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 11

This is a graph displaying the percent of patient improvement in pain from baseline for three different daily doses of Pregabalin and a placebo. There are no additional details available.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 12

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 13

This appears to be a graph or chart displaying the percentage of subjects who improved over a 12-week period, with Pregabaline and Placebo as the two compared treatments. The x-axis runs from 0 to 20, and it seems that the y-axis indicates percentages. However, without further context or a clearer image, it is impossible to provide a more detailed description or interpretation of the data.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 14

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 15

Not available. The text appears to be a mixture of random characters, symbols, and numbers and does not provide any useful information.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 16

This is a medication called Pregabalin presented in capsule form. Each capsule contains 53G of Pregabal IS and is accompanied by prescribing information. The instructions indicate that the medication should be stored at a temperature of 15-20°C/, and that it should only be dispensed to patients with a accompanying medication guide. Additionally, a batch overprinting area is provided for later commercial packing.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 17

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 18

This is a prescription drug called Pregabalin. It is available in the form of capsules manufactured by Cipla Ltd, Kurkumbh, India. The drug should be stored at a temperature between 15°C to 30°C and should be kept out of the reach of children. The medication guide must be dispensed to each patient. The text also includes manufacturing and batch details.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 19

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 20

This is a medication packaging for Pregabalin 75 mg capsules manufactured by Gipla USA, Inc. The medication guide must be dispensed to each patient. The storage temperature of the medication is between 15°C to 30°C. It's important to keep out of reach of children. The direction of unwinding is not available.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 21

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 22

This is a description of Pregabalin capsules manufactured by Cipla USA, Inc. The capsules come in 100 mg strength and contain Pregabalin USP. The medication guide must be dispensed by the pharmacist to each patient. The capsules must be stored at 25°C (77F) and kept out of reach of children. The unwinding direction, batch overprinting area, and expiry details are also included on the packaging.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 23

Description not available.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 24

This is a description of a medication called Pregabalin. It comes in the form of capsules, with each capsule containing 150mg of Pregabalin USP. It is manufactured by Cipla Ltd in Kurkumbh, India, and is distributed by Cipla USA, Inc. The medication is only available with a prescription and must be dispensed in child-resistant containers. The pharmacist's address is provided for reference. Additionally, the medication guide should be provided to each patient. There is an area for batch overprinting, which includes the serial number, expiry, and lot number during commercial packing. It should be stored at 25°C and can be stored at a range of 15°C-30°C.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 25

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 26

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 27

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 28

This is a description of a medication called Pregabalin. It is available in capsule form and each capsule contains 225mg Pregabalin. The medication should be stored in a child-resistant container at a temperature of 15°C-30°C. It is manufactured by Clpla Ltd in India and distributed in the USA by Clpla USA, Inc. The pharmacist is advised to dispense the medication guide to each patient. There is additional text related to batch overprinting in a commercial packing area.*

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 29

FDA Label Image

03a1965c 9956 486f 8599 7f5ecbf6c3b5 30

This is a medication label for Pregabalin capsules manufactured by Clpla Ltd. The capsules are intended for RxOnly use and should be stored at room temperature. The label contains dosage and usage instructions and advises to keep the medication in a child-resistant container out of reach of children. The label also provides the manufacturing location for the capsules and the address of the manufacturer. A medication guide should be included with each prescription. There is a section for batch overprinting that includes serial number, expiry, and lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.